Stauss HJ - Search Results

1

The effect of spike mutations on SARS-CoV-2 neutralization.

Rees-Spear C, Muir L, Griffith SA, Heaney J, Aldon Y, Snitselaar JL, Thomas P, Graham C, Seow J, Lee N, Rosa A, Roustan C, Houlihan CF, Sanders RW, Gupta RK, Cherepanov P, Stauss HJ, Nastouli E; SAFER Investigators; Doores KJ, van Gils MJ, McCoy LE. Rees-Spear C, et al. Among authors: stauss hj. Cell Rep. 2021 Mar 23;34(12):108890. doi: 10.1016/j.celrep.2021.108890. Epub 2021 Mar 6. Cell Rep. 2021. PMID: 33713594 Free PMC article.

2

Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients.

Carr EJ, Wu M, Harvey R, Wall EC, Kelly G, Hussain S, Howell M, Kassiotis G, Swanton C, Gandhi S, Bauer DL; Haemodialysis COVID-19 consortium; Crick COVID Immunity Pipeline; Billany RE, Graham-Brown MP, Beckett J, Bull K, Shankar S, Henderson S, Motallebzadeh R, Salama AD, Harper L, Mark PB, McAdoo S, Willicombe M, Beale R. Carr EJ, et al. Lancet. 2021 Sep 18;398(10305):1038-1041. doi: 10.1016/S0140-6736(21)01854-7. Epub 2021 Aug 13. Lancet. 2021. PMID: 34391504 Free PMC article. No abstract available.

3

Advances in tumour immunotherapy.

King J, Waxman J, Stauss H. King J, et al. QJM. 2008 Sep;101(9):675-83. doi: 10.1093/qjmed/hcn050. Epub 2008 May 13. QJM. 2008. PMID: 18477644 Review.

4

Immune response to human papillomavirus type 16 E6 gene in a live vaccinia vector.

Gao L, Chain B, Sinclair C, Crawford L, Zhou J, Morris J, Zhu X, Stauss H. Gao L, et al. J Gen Virol. 1994 Jan;75 ( Pt 1):157-64. doi: 10.1099/0022-1317-75-1-157. J Gen Virol. 1994. PMID: 7509369

5

Engineering CD4+ T Cells to Enhance Cancer Immunity.

Sillito F, Holler A, Stauss HJ. Sillito F, et al. Among authors: stauss hj. Cells. 2020 Jul 18;9(7):1721. doi: 10.3390/cells9071721. Cells. 2020. PMID: 32708397 Free PMC article. Review.

6

Monoclonal T-cell receptors: new reagents for cancer therapy.

Stauss HJ, Cesco-Gaspere M, Thomas S, Hart DP, Xue SA, Holler A, Wright G, Perro M, Little AM, Pospori C, King J, Morris EC. Stauss HJ, et al. Mol Ther. 2007 Oct;15(10):1744-50. doi: 10.1038/sj.mt.6300216. Epub 2007 Jul 17. Mol Ther. 2007. PMID: 17637721 Free article. Review.

7

Induction of cytotoxic T lymphocytes with peptides in vitro: identification of candidate T-cell epitopes in human papilloma virus.

Stauss HJ, Davies H, Sadovnikova E, Chain B, Horowitz N, Sinclair C. Stauss HJ, et al. Proc Natl Acad Sci U S A. 1992 Sep 1;89(17):7871-5. doi: 10.1073/pnas.89.17.7871. Proc Natl Acad Sci U S A. 1992. PMID: 1381502 Free PMC article.

8

Both immunization with protein and recombinant vaccinia virus can stimulate CTL specific for the E7 protein of human papilloma virus 16 in H-2d mice.

Zhu X, Tommasino M, Vousden K, Sadovnikava E, Rappuoli R, Crawford L, Kast M, Melief CJ, Beverley PC, Stauss HJ. Zhu X, et al. Among authors: stauss hj. Scand J Immunol. 1995 Nov;42(5):557-63. doi: 10.1111/j.1365-3083.1995.tb03696.x. Scand J Immunol. 1995. PMID: 7481562

9

Tumor-associated E6 protein of human papillomavirus type 16 contains an unusual H-2Kb-restricted cytotoxic T cell epitope.

Gao L, Walter J, Travers P, Stauss H, Chain BM. Gao L, et al. J Immunol. 1995 Dec 15;155(12):5519-26. J Immunol. 1995. PMID: 7499833

10

Limitations of predictive motifs revealed by cytotoxic T lymphocyte epitope mapping of the human papilloma virus E7 protein.

Sadovnikova E, Zhu X, Collins SM, Zhou J, Vousden K, Crawford L, Beverley P, Stauss HJ. Sadovnikova E, et al. Among authors: stauss hj. Int Immunol. 1994 Feb;6(2):289-96. doi: 10.1093/intimm/6.2.289. Int Immunol. 1994. PMID: 7512375

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

130 results

Search Page